Navigation Links
Fero Industries, Inc. Changes Name to PharmaRoth Labs, Inc.
Date:3/25/2013

LAS VEGAS, March 25, 2013 /PRNewswire/ -- PharmaRoth Labs, Inc. (OTCPink: FROI) the exclusive producer, marketer & distributor of Sucanon®, an oral Type-II Diabetes treatment, announced today that the name of the company has been changed from Fero Industries, Inc. to PharmaRoth Labs, Inc. The company also relocated corporate headquarters to Las Vegas, Nevada from Canada.

Luis Lopez , CEO of PharmaRoth Labs states: "We changed the name to PharmaRoth Labs to better reflect our business. We are also in the process of changing our ticker symbol as well. In addition, we moved our official office to Nevada, as our CFO Barry Hall is located there. These changes exemplify our desire to move the company forward and be better positioned corporately. We will announce the ticker symbol change when we receive the notification. We have not changed the web address yet, but have purchased the URL of www.pharmaroth.com."

About Sucanon®

Sucanon® is one of only three approved drugs in the multi-billion dollar market for a class of diabetic medications called "insulin sensitizers".  Pre-clinical and clinical studies show that Sucanon® and other insulin sensitizers lower a patient's blood sugar by increasing the muscle, fat and liver's sensitivity to the body's own naturally produced insulin.  Sucanon® has been approved for prescription sale in China and Peru.  Sucanon® is also approved as an OTC treatment for Type-II diabetes by regulatory authorities in Mexico.

For further information regarding Sucanon®, please visit PharmaRoth Labs, Inc. website at www.feroindustries.com.

About PharmaRoth Labs, Inc.

PharmaRoth Labs, Inc. (OTCPink: FROI) is focused on diabetes prevention and treatments.  The Company holds the intellectual property and all exclusive world-wide rights related to the production, marketing, and distribution of Sucanon®, an oral treatment for Type-II diabetes.  Sucanon® is a member of a class of diabetic medications called insulin sensitizers.  Insulin sensitizers lower blood sugar by increasing the muscle, fat and liver's sensitivity to insulin.  Insulin sensitizers are blood sugar normalizing or euglycemic drugs that help return the blood sugar to the normal range without the risk of low blood sugars.  PharmaRoth's strategy is to increase awareness, acceptance, and distribution of Sucanon® globally.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For investor relations contact:

Michael Irving 
Paramount Advisors, LLC
(407) 878-5462


'/>"/>
SOURCE PharmaRoth Labs, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lakeland Industries, Inc. Announces Completion of Line of Credit with HSBC UK
2. Fero Industries, Inc. Issues Corporate Update
3. Sun Pharmaceutical Industries, Inc. Issues Nationwide Voluntary Recall of One Lot of Nimodipine Capsules due to Crystallization of the Fill Material
4. Lower Operating Expense Augments Digital X-rays Uptake Across Industries, Finds Frost & Sullivan
5. Amendia, Inc. and Medline Industries, Inc. Announce Investment and Strategic Business Alliance
6. Medicare Recipients Will Suffer from Alarming New Changes by the CMS, Says MetroStar Home Health COO Isaac Newman
7. Hospira Announces Executive Changes
8. Pharmacy Technician Certification Board Announces Certification Program Changes
9. Power Wheelchairs Supplier MedSupplyShop.com Highlights Upcoming Changes to Medicare Competitive Bidding Program
10. Uroplasty Announces Executive Changes In US Sales Organization
11. HOLOGIC ANNOUNCES ORGANIZATIONAL CHANGES TO ITS DIAGNOSTICS SEGMENT; INTEGRATION OF GEN-PROBE PROCEEDING AHEAD OF SCHEDULE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... , Sept. 6, 2017  Robert G. Szewc, M.D., ... Professional Member in recognition of his contributions to the ... as a Nephrologist at the practice of Kidney and ... kidney care and hypertension solutions. He has worked in ... of career experience, as well as expertise in kidneys, ...
(Date:9/6/2017)... N.Y. , Sept. 6, 2017   PDI , ... announced it will host an educational session focused on ... bloodstream infection (CLABSI) prevention at the 2017 Annual Scientific ... which will take place at the Phoenix ... from Sept. 16-19, will also feature PDI,s ...
(Date:9/6/2017)... Eli Lilly and Company (NYSE: ... for galcanezumab and lasmiditan, two investigational treatments for migraine, ... (IHC) taking place Sept. 7-10 in Vancouver ... long-term data from an open-label study evaluating the safety ... and 240 mg) for the prevention of migraine. Galcanezumab ...
Breaking Medicine Technology:
(Date:9/26/2017)... ... September 26, 2017 , ... ... **An FDAnews Management Report**, http://www.fdanews.com/products/54648-principles-of-equipment-qualification      , The FDA ... prove that their equipment, operations and processes all work the way they’re ...
(Date:9/26/2017)... Washington, Connecticut (PRWEB) , ... September 26, 2017 , ... ... next five decades growing into an innovative leader in special education. In 2018, ... half century. , Glenholme, formerly a world renowned horse farm for Hackney show ponies, ...
(Date:9/26/2017)... ... September 26, 2017 , ... Autism Learning Partners (“ALP”) announces ... Autism, A Division of Autism Learning Partners, will be the first ALP affiliate ... based Autism services in Broomfield and will continue to operate with its current ...
(Date:9/26/2017)... ... 26, 2017 , ... DETECTO has been awarded ... 2017, the new agreement allows Premier members, at their discretion, to take advantage ... is pleased to renew our agreement with Premier to be able to supply ...
(Date:9/26/2017)... ... 26, 2017 , ... “How to Live in the Millennium”: a gripping take on how ... no longer a part of everyday life and do not affect daily choices. It ... for the thoughts, words, and actions that are chosen. “How to Live in the ...
Breaking Medicine News(10 mins):